Safety study of MAR002 in healthy men
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.
This early-phase trial tests a new investigational drug called MAR002 in healthy men. The goal is to see how safe the drug is and how the body handles it before moving to larger studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a man between 18 and 40 years old.
- You must weigh between 121 and 209 pounds (55 to 95 kg) and have a body mass index (BMI) between 18 and 30.
- You must be generally healthy with no serious medical conditions.
- You cannot have a history of cancer, allergies to similar drugs, or certain infections like HIV or hepatitis.
- You cannot use nicotine products or have a history of substance abuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called MAR002 to treat acromegaly, a hormone disorder caused by a pituitary tumor that makes too much growth hormone. The drug is designed to help lower hormone levels and improve symptoms.
This study follows people with acromegaly to better understand how treatments are used in real life and how well they work over time. It may help improve future treatment choices by comparing outcomes across different care patterns.
This trial tests a new medication, Debio 4126, for people with acromegaly who are already being treated with octreotide or lanreotide. The goal is to see if it can help control hormone levels and is safe to use.
This trial tests whether octreotide long-acting injection—a medication that lowers growth hormone and IGF-1 levels—can effectively control acromegaly symptoms. Acromegaly is a condition where the body makes too much growth hormone, causing abnormal growth. This study aims to confirm the treatment works safely and effectively.
This study tests a new medicine called MAR001 in people with high triglycerides and remnant cholesterol, which are types of fats in the blood. It aims to see if the medicine can improve these levels while you stick to your usual diet and medications.
This trial tests a new drug, SRK-439, in healthy adults to see how safe it is and how the body processes it. It helps learn the right dose for future studies.
Hear when a new Acromegaly trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.